{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:08:01Z","timestamp":1737522481655,"version":"3.33.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1136\/ard.55.7.478","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"478-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs."],"prefix":"10.1016","volume":"55","author":[{"given":"R","family":"Addyman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Beyeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Astbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A","family":"Bird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198106010-00001","article-title":"Clinical implications of enzyme induction and enzyme inhibition","volume":"6","author":"K, Park B.; M, Breckenridge A.","year":"1981","unstructured":"Park B K, Breckenridge A M. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet 1981; 6: 1-24.","journal-title":"Clin Pharmacokinet"},{"key":"ref_2","first-page":"314","article-title":"Inherited defects of hepatic drug metabolism","volume":"3","author":"Kupfer, A.; Preisig, R.","year":"1983","unstructured":"Kupfer A, Preisig R. Inherited defects of hepatic drug metabolism. Semin Liver Dis 1983; 3: 314-54.","journal-title":"Semin Liver Dis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0006-2952(70)90202-9","article-title":"The effects of adjuvant induced arthritis on the liver metabolism of drugs in rats","volume":"19","author":"M, Morton D.; H, Chatfield D.","year":"1970","unstructured":"Morton D M, Chatfield D H. The effects of adjuvant induced arthritis on the liver metabolism of drugs in rats. Biochem Pharmacol 1970; 19: 473-81.","journal-title":"Biochem Pharmacol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/0006-2952(73)90348-1","article-title":"Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism","volume":"22","author":"J, Beck F.; W, Whitehouse M.","year":"1973","unstructured":"Beck F J, Whitehouse M W. Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism. Biochem Pharmacol 1973; 22: 2453-68.","journal-title":"Biochem Pharmacol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(76)90257-4","article-title":"Adjuvant-induced arthritis and drug metabolizing enzymes","volume":"25","author":"A, Cawthorne M.; D, Palmer E.; J, Green","year":"1976","unstructured":"Cawthorne M A, Palmer E D, Green J. Adjuvant-induced arthritis and drug metabolizing enzymes. Biochem Pharmacol 1976; 25: 2683-8.","journal-title":"Biochem Pharmacol"},{"key":"ref_6","first-page":"115","article-title":"u-Glucaric acid in rheumatoid arthritis","volume":"2","author":"McKenna, F.; Coombes, G.; Sandle, L.; Mather, H.","year":"1992","unstructured":"McKenna F, Coombes G, Sandle L, Mather H. u-Glucaric acid in rheumatoid arthritis [abstract]. Br Jf Rheumatol 1992; 31 (suppl 2): 115.","journal-title":"Br Jf Rheumatol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-2952(65)90204-2","article-title":"Evidence for the function of D-glucarcid acid as an indicator for drug induced enhanced metabolism through the glucuronic acid pathway in man","volume":"14","author":"M, Aarts E.","year":"1965","unstructured":"Aarts E M. Evidence for the function of D-glucarcid acid as an indicator for drug induced enhanced metabolism through the glucuronic acid pathway in man. Biochem Pharmacol 1965; 14: 359-63.","journal-title":"Biochem Pharmacol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cpt1974154417","article-title":"Glucaric acid as an indicator of use of enzyme-inducing drugs","volume":"15","author":"A, Sotaumi E.; F, Medzihradsky; G, Eliasson","year":"1974","unstructured":"Sotaumi E A, Medzihradsky F, Eliasson G. Glucaric acid as an indicator of use of enzyme-inducing drugs. Clin Pharmacol Ther 1974; 15: 417-23.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.0.0420585","article-title":"Developmental effects of liver D-glucuronolactone dehydrogenase levels on D-glucaric acid excretion in urine; hormal effects on i-glucaric acid excretion in urine","volume":"42","author":"P, Mowat A.","year":"1968","unstructured":"Mowat A P. Developmental effects of liver D-glucuronolactone dehydrogenase levels on D-glucaric acid excretion in urine; hormal effects on i-glucaric acid excretion in urine. JEndocrinol 1968; 42: 585-90.","journal-title":"JEndocrinol"},{"key":"ref_10","first-page":"209","article-title":"Changes in enzyme activity related to n-glucaric acid synthesis with age, pregnancy and malignancy","volume":"28","author":"A, Marsh C.; J, Carr","year":"1965","unstructured":"Marsh C A, Carr J. Changes in enzyme activity related to n-glucaric acid synthesis with age, pregnancy and malignancy. Clin Sci 1965; 28: 209-17.","journal-title":"Clin Sci"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0006-2952(73)90405-X","article-title":"Urinary i-glucaric acid excretion and total liver content of cytochrome P450 in guinea pigs: relationship during enzyme induction and following inhibition of protein synthesis","volume":"22","author":"Hunter, J.; D, Maxwell J.; A, Stewart D.; Williams, R.","year":"1973","unstructured":"Hunter J, Maxwell J D, Stewart D A, Williams R. Urinary i-glucaric acid excretion and total liver content of cytochrome P450 in guinea pigs: relationship during enzyme induction and following inhibition of protein synthesis. Biochem Pharnacol 1973; 22: 743-7.","journal-title":"Biochem Pharnacol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.1975.tb01584.x","article-title":"Effect of phenobarbitone on hepatic drug-metabolising enzymes and urinary i-glucaric acid excretion in man","volume":"2","author":"S, Lecamwasam D.; C, Franklin; P, Turner","year":"1975","unstructured":"Lecamwasam D S, Franklin C, Turner P. Effect of phenobarbitone on hepatic drug-metabolising enzymes and urinary i-glucaric acid excretion in man. Br J Clin Pharmacol 1975; 2: 257-62.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_13","first-page":"249","article-title":"Ethosyximide: liver enzyme induction and n-glucaric acid excretion","volume":"1","author":"C, Gilbert J.; K, Scott A.; B, Galloway D.; C, Petric J.","year":"1974","unstructured":"Gilbert J C, Scott A K, Galloway D B, Petric J C. Ethosyximide: liver enzyme induction and n-glucaric acid excretion. BrJClin Pharmacol 1974; 1: 249-52.","journal-title":"BrJClin Pharmacol"},{"key":"ref_14","first-page":"572","article-title":"D-glucaric acid excretion as a test for hepatic enzyme induction in man","volume":"i:","author":"HunterJ, MaxwellJ D.; M, Carrella; A, Stewart D.; R, Williams","year":"1971","unstructured":"HunterJ, MaxwellJ D, Carrella M, Stewart D A, Williams R. D-glucaric acid excretion as a test for hepatic enzyme induction in man. Lancet 1971; i: 572-5.","journal-title":"Lancet"},{"key":"ref_15","first-page":"315","article-title":"revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"C, Arnett F.; M, Edworthy S.; D, Bloch","year":"1987","unstructured":"Arnett F C, Edworthy S M, Bloch D, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.","journal-title":"The American Rheumatism Association"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0009-8981(74)90060-6","article-title":"Urinary i-glucaric acid assay by an improved enzymatic procedure","volume":"51","author":"J, Simmons C.; M, Davis; B, Dordoni; R, Williams","year":"1974","unstructured":"Simmons C J, Davis M, Dordoni B, Williams R. Urinary i-glucaric acid assay by an improved enzymatic procedure. Clin ChimActa 1974; 51: 47-51.","journal-title":"Clin ChimActa"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.55.7.478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:40:35Z","timestamp":1737448835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["S0003496724002942"],"URL":"https:\/\/doi.org\/10.1136\/ard.55.7.478","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1996,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.55.7.478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}